Editor of Patient Care Online.
Novel Oral Antiobesity Drug Shown to Reduce Body Weight by up to 13% in First-In-Human Study
EASD 2024: Amycretin was also found to be safe and well tolerated in adults with obesity and without diabetes.
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose
Your daily dose of the clinical news you may have missed.
Good Cardiovascular Health Early on May Offset Genetic Risk of Hypertensive Disorders of Pregnancy
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
Corticosteroid Phobia among Individuals with Chronic Hand Eczema: Daily Dose
Mental Health Among Adolescents With Obesity: Daily Dose
Best States for Health Care in the US: 2024
Which state retains the most medical residents? Or has the lowest cancer rate? Answers and more insights from a nationwide analysis, here.
Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose
Survodutide: Novel GCGR/GLP-1RA Shows Promise in Obesity, MASH Treatment
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.
Healthy Lifestyle May Offset Brain Aging Accelerated by Diabetes: Daily Dose
Lebrikizumab Therapy Improved QoL, Mental Health Outcomes in Patients with Atopic Dermatitis
In a study of persons with moderate-to-severe atopic dermatitis, lebrikizumab monotherapy for 16 weeks resulted in improved quality of life and mental health.
FDA Expands Omnipod 5 AID System Label to Treat T2D: Daily Dose
Tralokinumab May be Beneficial for Atopic Dermatitis Treatment in Special Patient Populations
In a study of patients with atopic dermatitis, tralokinumab was effective and safe in elderly patients and those with severe comorbidities.
Global Study Builds on Previous Research Linking Semaglutide & Suicide: Daily Dose
CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose
Many Patients with Chronic Hand Eczema Report Having Corticosteroid Phobia, Shows New Research
In a study of patients with CHE, 75.5% of participants totally or almost agreed that topical corticosteroids cause damage to skin.
Updated mRNA COVID-19 Vaccines: Daily Dose
Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction
ESC 2024: Findings from the FINEARTS-HF clinical trial provide the first definite evidence that an MRA can be beneficial in patients with HFmrEF/HFpEF.
Regular Aspirin Use for CRC Prevention Found to Benefit Unhealthy Adults Most: Daily Dose
FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose
Recreational Drug Users Face Triple the Risk of Repeat Major Adverse CV Events vs Non-Users
ESC 2024: Cannabis, opioid, and MDMA use were most strongly tied to cardiovascular event risk, according to a new study.
Geography May Matter in Dementia Diagnosis: Daily Dose
PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose
T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association
Type 2 diabetes and prediabetes were associated with accelerated brain aging, particularly among men and persons with poor cardiometabolic health, according to new research.
New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment
In a study of adolescents with obesity, symptoms of depression and eating disorders decreased over the course of a 52-week intensive behavioral intervention.
Global Disparities in Cancer Cases, Deaths Among Men: Daily Dose
FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.
Suicide Rates in US Preteens: Daily Dose
Semaglutide & Suicide: Large Analysis from WHO Data Builds on Previous Research Linking the Two
Results of a global analysis of over 30 million cases showed significantly higher odds for suicidal ideation among adults who received semaglutide vs other medications.
Plant-Based Fats Reduce Risk for Overall, CVD Death: Daily Dose